Stanford scientists have discovered a DNA methylation signature on circulating tumor DNA (ctDNA) that can distinguish between the aggressive Leiomyosarcoma (LMS) from its benign counterpart leiomyoma (LM) in the uterus.
Researchers at Stanford have developed a novel T cell engineering platform that leverages constitutively active interleukin-9 receptor (IL-9R) signaling to improve the efficacy and scalability of immunotherapies for solid tumors.
Stanford scientists have developed a new DNA-based technology that allows therapeutic genes to be maintained in human cells for extended periods without altering the cell's chromosomes.
Stanford scientists have developed a high-throughput cell-based peptide display platform for screening peptide variants that modulate G protein-coupled receptors (GPCRs).
Stanford researchers have developed the Large-scale Electrophysiology Amplification Platform (LEAP), a wireless, label-free optical system for monitoring the electrical activity of neurons and heart cells.
Researchers at Stanford have developed an innovative, non-invasive thermal treatment to recover the lost capacity of used lithium-ion batteries (LIBs), offering a scalable and cost-effective solution to the environmental challenges posed by battery waste.
Stanford researchers developed and patented a multiplexed immunohistochemistry method called multiplexed ion beam imaging (MIBI), which uses antibodies tagged with non-biological elemental isotopes (e.g. rare earth elements) and secondary ion mass spectroscopy.
Stanford scientists have developed fully human CD19-targeted CAR T cells designed to overcome the limitations of current CAR T cell therapies, particularly in treating low CD19 density blood cancers.
Stanford researchers have developed a novel, multi-specific chimeric antigen receptor (CAR) T-cell therapy designed to overcome the key challenges of treating solid tumors, including tumor heterogeneity, immune evasion, and CAR T-cell exhaustion.
Riffbot.ai is a web-based platform that leverages AI-powered, customizable chatbots to generate dynamic, personalized self-reflection experiences for learners while providing real-time insights to enhance engagement and improve learning outcomes at scale.
Stanford researchers have developed a novel, inverse-designed wavelength division multiplexer (WDM) that integrates high-performance Bragg gratings for use in optical communication systems.
Researchers at Stanford have developed an innovative molecular engineering strategy to enhance the stability and performance of polymer semiconductors (PSCs).
Stanford researchers have developed a highly effective B7-H3 chimeric antigen receptor (CAR) for CAR-T cell therapy, designed to enhance binding and cytotoxicity against B7-H3 expressing solid tumors, offering a promising treatment for various cancers.
Stanford scientists have discovered that a specific protein signaling pathway can promote regenerative wound healing by suppressing fibrosis-related mechanosignaling.